CRSP

CRISPR THERAPEUTICS AG

Healthcare | Mid Cap

-$1.15

EPS Forecast

$4.04

Revenue Forecast

Announcing earnings for the quarter ending 2026-03-31T00:00:00 soon
DNLIDenali Therapeutics IncNVAXNovavax IncNBIXNeurocrine Biosciences IncRGENRepligen CorpTECHBio-techne CorpMRNAModerna IncHALOHalozyme Therapeutics IncIOVAIovance Biotherapeutics IncREPLReplimune Group Inc